Trenizine
- Level
- Commodity
- Parent
- 51313500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313511This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WPQ720NCK. European Medicines Agency schedules Trenizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11234MIG. Trenizine generally arises in the molecular formula C31H40N2O. The term TRENIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) TRENIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trenizine under HS 29335995 and SITC 51576. As of Q4 2014, TRENIZINE remains the US FDA Preferred Term for this commodity. Trenizine bears US NLM identifiers UMLS ID C1883389 and NCI Concept Code C66622. SMILES: OC(CCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1)C1CCC(C(C)(C)C)CC1.
Same parent
Under 51313500 · 13Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.